The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany

被引：0
|
作者：
Gessner, C. [1 ]
Akyildiz, B. [2 ]
Nachtigall, D. [2 ]
Nudo, E. [3 ]
Boeing, S. [4 ]
Timmermann, H. [5 ]
机构：
[1] POIS, Leipzig, Germany
[2] Chiesi GmbH, Hamburg, Germany
[3] Global Med Affairs, Chiesi Farmaceutici, Parma, Italy
[4] Specialized Practice Pulm & Bronchial Med, Allergol & Sleep Med, Meerbusch, Germany
[5] Allergopraxis Hamburg, Hamburg, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1239
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world evidence with extrafine single-inhaler triple therapy in asthma: the TriMaximize study
    Gessner, C.
    Akyildiz, B.
    Cesarz, K.
    Sauer, A.
    Bogoevska, V
    Criee, P. C.
    [J]. PNEUMOLOGIE, 2022, 76 : S7 - S8
  • [2] Improvement of asthma control after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Greulich, T.
    Akyildiz, B.
    Slawinska, R.
    Wendt, A.
    Bogoevska, V
    Gessner, C.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [3] Change in asthma control after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Greulich, T.
    Akyildiz, B.
    Nachtigall, D.
    Bogoevska, V
    Gessner, C.
    [J]. PNEUMOLOGIE, 2023, 77 : S29 - S29
  • [4] Real-World Outcomes on Spacer used with Extrafine Single-Inhaler Triple Therapy in Asthma Patients-TriMaximize Study
    Trinkmann, F.
    Nachtigall, D.
    Bogoevska, V
    Akyildiz, B.
    Borucki, T.
    Grickschat, V
    Gessner, C.
    [J]. PNEUMOLOGIE, 2024, 78 : S4 - S4
  • [5] TriOptimize X: Improved adherence by extrafine single-inhaler triple therapy in real-world
    Criee, C.
    Trinkmann, F.
    Gueldenring, S.
    Loeper, N.
    Bogoevska, V
    Gessner, C.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [6] Change in lung function after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Gessner, C.
    Akyildiz, B.
    Wendt, A.
    Licht, B.
    Criee, C.
    [J]. PNEUMOLOGIE, 2023, 77 : S36 - S36
  • [7] Impact of extrafine single-inhaler triple therapy on treatment adherence after 6 months of treatment in asthmatics: a real-world view from Germany
    Trinkmann, Autoren F.
    Akyildiz, B.
    Grickschat, V
    Borucki, T.
    Gessner, C.
    [J]. PNEUMOLOGIE, 2023, 77 : S35 - S36
  • [8] Improvement of treatment adherence after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
    Gessner, C.
    Akyildiz, B.
    Grickschat, V
    Borucki, T.
    Trinkmann, F.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [9] Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and HRQoL After Three Months: TriMaximize - A Real-world View in Asthma Therapy from Austria
    Sator, L.
    Reisinger, M.
    Voves, R. V.
    Nevels, R.
    Hoermannstorfer-Fessl, K.
    Keckeis, A.
    Tiefenbacher, F.
    Ambrosch, G.
    Wuertz, M.
    Feizelmeier, H.
    Petrovic, M.
    Pohl, W.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 563 - 564
  • [10] TriOptimize II: The Use of Blood Eosinophil Count in the Care of Patients with COPD Prescribed Single Inhaler Triple Therapy: A Real-World View from Germany
    Hoevelmann, R.
    Javan, S. Bahari
    Melchior, K.
    Gessner, C.
    Pfeffermann, A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345